Development of agents that modulate protein-protein interactions in membranes

Current Pharmaceutical Design

Volumn 16, Issue 9, 2010, Pages 1055-1062

  Zhao, Tina X ^a   Martinko, Alexander J ^a   Le, Vy H ^a   Zhao, Jing ^b   Yin, Hang ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NANJING UNIVERSITY   (China)

Author keywords

Integral membrane proteins; Peptide; Protein protein interactions; Rational drug design; Transmembrane domains

Indexed keywords

AMINO ACID DERIVATIVE; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BILAYER MEMBRANE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; EUKARYOTIC CELL; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROKARYOTIC CELL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW;

ANIMALS; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING;

EID: 77950262907     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790963878     Document Type: Review

References (94)

1. Auerbach D, Thaminy S, Hottiger MO, Stagljar I. The post-genomic era of interactive proteomics: facts and perspectives. Proteomics 2002; 2: 611-623
2. Thaminy S, Auerbach D, Arnoldo A, Stagljar I. Identification of novel ErbB3-interacting factors using the split-ubiquitin membrane yeast two-hybrid system. Genome Res 2003; 13: 1744-1753
3. Yin H, Slusky JS, Berger BW, Walters RS, Vilaire G, Litvinov RI, et al. Computational design of peptides that target transmembrane helices. Science 2007; 315: 1817-1822
4. Senes A, Chadi DC, Law PB, Walters RF, Nanda V, Degrado WF. E(z), a depth-dependent potential for assessing the energies of insertion of amino acid side-chains into membranes: derivation and applications to determining the orientation of transmembrane and interfacial helices. J Mol Biol 2007; 366: 436-448
5. Rausch JM, Marks JR, Wimley WC. Rational combinatorial design of pore-forming beta-sheet peptides. Proc Natl Acad Sci USA 2005; 102: 10511-10515
6. Rausch JM, Marks JR, Rathinakumar R, Wimley WC. β-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes. Biochemistry 2007; 46: 12124-12139
7. Freeman-Cook LL, Dixon AM, Frank JB, Xia Y, Ely L, Gerstein M, et al. Selection and characterization of small random transmembrane proteins that bind and activate the platelet-derived growth factor beta receptor. J Mol Biol 2004; 338: 907-920
8. Mitra K, Ubarretxena-Belandia I, Taguchi T, Warren G, Engelman DM. Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc Natl Acad Sci USA 2004; 101: 4083-4088
9. Mouritsen OG, Bloom M. Mattress model of lipid-protein interactions in membranes. Biophys J 1984; 46: 141-153
10. Smondyrev AM, Berkowitz ML. Structure of dipalmitoylphosphatidylcholine/ cholesterol bilayer at low and high cholesterol concentrations: molecular dynamics simulation. Biophys J 1999; 77: 2075-2089
11. Nezil FA, Bloom M. Combined influence of cholesterol and synthetic amphiphillic peptides upon bilayer thickness in model membranes. Biophys J 1992; 61: 1176-1183
12. Hui SW, He NB. Molecular organization in cholesterol-lecithin bilayers by X-ray and electron diffraction measurements. Biochemistry 1983; 22: 1159-1164
13. Engelman DM. Lipid bilayer structure in the membrane of Mycoplasma laidlawii. J Mol Biol 1971; 58: 153-165
14. Lewis BA, Engelman DM. Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. J Mol Biol 1983; 166: 211-217
15. Munro S. Sequences within and adjacent to the transmembrane segment of α-2,6-sialyltransferase specify Golgi retention. EMBO J 1991; 10: 3577-3588
16. Munro S. An investigation of the role of transmembrane domains in Golgi protein retention. EMBO J 1995; 14: 4695-4704
17. Wallace BA, Cascio M, Mielke DL. Evaluation of methods for the prediction of membrane protein secondary structures. Proc Natl Acad Sci USA 1986; 83: 9423-9427
18. Li SC, Deber CM. A measure of helical propensity for amino acids in membrane environments. Nat Struct Biol 1994; 1: 368-373
19. Li SC, Deber CM. Peptide environment specifies conformation. Helicity of hydrophobic segments compared in aqueous, organic, and membrane environments. J Biol Chem 1993; 268: 22975-22978
20. White SH, Wimley WC. Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct 1999; 28: 319-365
21. Hessa T, Kim H, Bihlmaier K, Lundin C, Boekel J, Andersson H, et al. Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature 2005; 433: 377-381
22. Walters RF, DeGrado WF. Helix-packing motifs in membrane proteins. Proc Natl Acad Sci USA 2006; 103: 13658-13663
23. Gernert KM, Surles MC, Labean TH, Richardson JS, Richardson DC. The Alacoil: a very tight, antiparallel coiled-coil of helices. Protein Sci 1995; 4: 2252-2260
24. Russ WP, Engelman DM. The GxxxG motif: a framework for transmembrane helix-helix association. J Mol Biol 2000; 296: 911-919
25. Bowie JU. Solving the membrane protein folding problem. Nature 2005; 438: 581-589
26. DeGrado WF, Gratkowski H, Lear JD. How do helix-helix interactions help determine the folds of membrane proteins? Perspectives from the study of homo-oligomeric helical bundles. Protein Sci 2003; 12: 647-665
27. Senes A, Engel DE, DeGrado WF. Folding of helical membrane proteins: the role of polar, GxxxG-like and proline motifs. Curr Opin Struct Biol 2004; 14: 465-479
28. Adamian L, Liang J. Interhelical hydrogen bonds and spatial motifs in membrane proteins: polar clamps and serine zippers. Proteins 2002; 47: 209-218
29. Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, Bowie JU. Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 2005; 102: 14278-14283
30. Weiss MS, Brandl M, Suhnel J, Pal D, Hilgenfeld R. More hydrogen bonds for the (structural) biologist. Trends Biochem Sci 2001; 26: 521-523
31. Senes A, Ubarretxena-Belandia I, Engelman DM. The Cα - H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc Natl Acad Sci USA 2001; 98: 9056-9061
32. Javadpour MM, Eilers M, Groesbeek M, Smith SO. Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association. Biophys J 1999; 77: 1609-1618
33. MacKenzie KR, Engelman DM. Structure-based prediction of the stability of transmembrane helix-helix interactions: the sequence dependence of glycophorin A dimerization. Proc Natl Acad Sci USA 1998; 95: 3583-3590
34. Rees DC, DeAntonio L, Eisenberg D. Hydrophobic organization of membrane proteins. Science 1989; 245: 510-513
35. Wahl MC, Sundaralingam M. C-H...O hydrogen bonding in biology. Trends Biochem Sci 1997; 22: 97-102.
36. Loll B, Raszewski G, Saenger W, Biesiadka J. Functional role of C(α)-H...O hydrogen bonds between transmembrane α-helices in photosystem I. J Mol Biol 2003; 328: 737-747
37. Savage DF, Egea PF, Robles-Colmenares Y, O'Connell JD, 3rd, Stroud RM. Architecture and selectivity in aquaporins: 2.5 a X-ray structure of aquaporin Z. PLoS Biol 2003; 1: E72.
38. Gratkowski H, Lear JD, DeGrado WF. Polar side chains drive the association of model transmembrane peptides. Proc Natl Acad Sci USA 2001; 98: 880-885
39. Zhou FX, Merianos HJ, Brunger AT, Engelman DM. Polar residues drive association of polyleucine transmembrane helices. Proc Natl Acad Sci USA 2001; 98: 2250-2255
40. Russ WP, Engelman DM. TOXCAT: a measure of transmembrane helix association in a biological membrane. Proc Natl Acad Sci USA 1999; 96: 863-868
41. Dawson JP, Weinger JS, Engelman DM. Motifs of serine and threonine can drive association of transmembrane helices. J Mol Biol 2002; 316: 799-805.
42. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395
43. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003; 55: 27-55.
44. Wimley WC. The versatile β-barrel membrane protein. Curr Opin Struct Biol 2003; 13: 404-411
45. Wimley WC, White SH. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 1996; 3: 842-848
46. Mrksich M, Whitesides GM. Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells. Annu Rev Biophys Biomol Struct 1996; 25: 55-78.
47. Lam KS, Lehman AL, Song A, Doan N, Enstrom AM, Maxwell J, et al. Synthesis and screening of "one-bead one-compound" combinatorial peptide libraries. Methods Enzymol 2003; 369: 298-322.
48. Rausch JM, Wimley WC. A high-throughput screen for identifying transmembrane pore-forming peptides. Anal Biochem 2001; 293: 258-263
49. Wang Z, Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res 2004; 32: D590-2.
50. Brahmachary M, Krishnan SP, Koh JL, Khan AM, Seah SH, Tan TW, et al. ANTIMIC: a database of antimicrobial sequences. Nucleic Acids Res 2004; 32: D586-9.
51. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature 1989; 340: 245-246
52. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000; 403: 623-627
53. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 2001; 98: 4569-4574
54. Stagljar I, Korostensky C, Johnsson N, te Heesen S. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc Natl Acad Sci USA 1998; 95: 5187-5192
55. Stagljar I, Fields S. Analysis of membrane protein interactions using yeast-based technologies. Trends Biochem Sci 2002; 27: 559-563
56. Gurezka R, Laage R, Brosig B, Langosch D. A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments. J Biol Chem 1999; 274: 9265-9270
57. Gerber D, Sal-Man N, Shai Y. Structural adaptation of the glycophorin A transmembrane homodimer to D-amino acid modifications. J Mol Biol 2004; 339: 243-250
58. Soong R, Merzlyakov M, Hristova K. Hill coefficient analysis of transmembrane helix dimerization. J Membr Biol 2009; 230: 49-55.
59. Merzlyakov M, Hristova K. Forster resonance energy transfer measurements of transmembrane helix dimerization energetics. Methods Enzymol 2008; 450: 107-127
60. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987; 56: 881-914.
61. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213-223
62. DiMaio D, Lai CC, Klein O. Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways. Annu Rev Microbiol 1998; 52: 397-421.
63. Schlegel R, Wade-Glass M, Rabson MS, Yang YC. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science 1986; 233: 464-467
64. Mattoon D, Gupta K, Doyon J, Loll PJ, DiMaio D. Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein. Oncogene 2001; 20: 3824-3834
65. Meyer AN, Xu YF, Webster MK, Smith AE, Donoghue DJ. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. Proc Natl Acad Sci USA 1994; 91: 4634-4638
66. Gerber D, Sal-Man N, Shai Y. Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization. J Biol Chem 2004; 279: 21177-21182
67. Mendrola JM, Berger MB, King MC, Lemmon MA. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J Biol Chem 2002; 277: 4704-4712
68. Langosch D, Brosig B, Kolmar H, Fritz HJ. Dimerisation of the glycophorin A transmembrane segment in membranes probed with the ToxR transcription activator. J Mol Biol 1996; 263: 525-530
69. Gerber D, Shai Y. In vivo detection of hetero-association of glycophorin-A and its mutants within the membrane. J Biol Chem 2001; 276: 31229-31232
70. Gerber D, Shai Y. Chirality-independent protein-protein recognition between transmembrane domains in vivo. J Mol Biol 2002; 322: 491-495
71. Lemmon MA, Flanagan JM, Hunt JF, Adair BD, Bormann BJ, Dempsey CE, et al. Glycophorin A dimerization is driven by specific interactions between transmembrane α-helices. J Biol Chem 1992; 267: 7683-7689
72. Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarski R, Yarden Y, Sela M. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 1997; 14: 2099-2109
73. Hurwitz E, Klapper LN, Wilchek M, Yarden Y, Sela M. Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies. Cancer Immunol Immunother 2000; 49: 226-234
74. Watson S, Arkinstall S. The G-protein-linked Receptor Facts Book. London: Academic Press, Ltd. 1994.
75. Tarasova NI, Rice WG, Michejda CJ. Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions. J Biol Chem 1999; 274: 34911-34915
76. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994; 269: 232-237
77. Sato M, Hresko R, Mueckler M. Testing the charge difference hypothesis for the assembly of a eucaryotic multispanning membrane protein. J Biol Chem 1998; 273: 25203-25208
78. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17: 657-700.
79. Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988; 6: 629-662
80. Manolios N, Collier S, Taylor J, Pollard J, Harrison LC, Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med 1997; 3: 84-88
81. Manolios N, Kemp O, Li ZG. The T cell antigen receptor alpha and beta chains interact via distinct regions with CD3 chains. Eur J Immunol 1994; 24: 84-92.
82. Whittaker RG, Hayes PJ, Bender VJ. A gentle method for linking Tris to amino acids and peptides. Pept Res 1993; 6: 125-128
83. Senes A, Gerstein M, Engelman DM. Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. J Mol Biol 2000; 296: 921-936
84. Huang Y, Lemieux MJ, Song J, Auer M, Wang DN. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 2003; 301: 616-620
85. Jordan P, Fromme P, Witt HT, Klukas O, Saenger W, Krauss N. Three-dimensional structure of cyanobacterial photosystem I at 2.5 A resolution. Nature 2001; 411: 909-917
86. Senes A, Engel DE, DeGrado WF. Folding of helical membrane proteins: the role of polar, GXXXG-like and proline motifs. Curr Opin Struc Biol 2004; 14: 465-479
87. Quintana FJ, Gerber D, Bloch I, Cohen IR, Shai Y. A structurally altered D,L-amino acid TCRα transmembrane peptide interacts with the TCRα and inhibits T-cell activation in vitro and in an animal model. Biochemistry 2007; 46: 2317-2325
88. Sal-Man N, Gerber D, Shai Y. Hetero-assembly between all-L- and all-D-amino acid transmembrane domains: forces involved and implication for inactivation of membrane proteins. J Mol Biol 2004; 344: 855-864
89. Tarasova NI, Seth R, Tarasov SG, Kosakowska-Cholody T, Hrycyna CA, Gottesman MM, et al. Transmembrane inhibitors of P-glycoprotein, an ABC transporter. J Med Chem 2005; 48: 3768-3775
90. Manolios N, Collier S, Taylor J, Pollard J, Harrison LC, Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med 1997; 3: 84-88
91. Gerber D, Quintana FJ, Bloch I, Cohen IR, Shai Y. D-enantiomer peptide of the TCR α transmembrane domain inhibits T-cell activation in vitro and in vivo. FASEB J 2005; 19: 1190-1192
92. Dimova EY, Michiels C, Kietzmann T. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Curr Pharm Des 2009; 15(33): 3867-3877
93. Gaestel M, Kracht M. Peptides as signaling inhibitors for mammalian MAP kinase cascades. Curr Pharm Des 2009; 15(21): 2471-2480
94. Mischiati C, Melloni E, Corallini F, Milani D, Bergamini C, Vaccarezza M. Potential role of PKC inhibitors in the treatment of hematological malignancies. Curr Pharm Des 2008; 14(21): 2075-2084